Findings

What do systematic reviews say?

8 questions · 14 findings · 1 reviews · Kidney and Transplant

No studies found 5 · 35.7%GRADE not reported 0 · 0%Very low 0 · 0%Low 7 · 50%Moderate 2 · 14.3%High 0 · 0%

PEG interferon alpha‐2a · patients on HD with HCV infection

High showed no clear difference in PEG interferon alpha‐2a compared with low dose pegylated interferon alpha‐2a or alpha‐2b (low certainty).

4 findings from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
RR 5.66 [0.69, 46.31]
1 study · 81 participants
Low
Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
RR 1.12 [0.4, 2.21]
1 study · 43 participants
Low
Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
RR 1.19 [0.79, 1.78]
1 study · 81 participants
Low

Show 1 more finding

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
RR 1.13 [0.64, 2]
1 study · 81 participants
Low

PEG interferon (alpha‐2b) · patients on HD with HCV infection

High showed no clear difference in PEG interferon alpha‐2b compared with low dose pegylated interferon alpha‐2a or alpha‐2b (low certainty).

2 findings from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
RR 2.4 [0.11, 51.32]
1 study · 16 participants
Low
Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
RR 5.6 [0.34, 93.35]
1 study · 16 participants
Low

PEG interferon (combined) · patients on HD with HCV infection

High showed no clear difference in PEG interferon (combined) compared with low dose pegylated interferon alpha‐2a or alpha‐2b (moderate certainty).

3 findings from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
RR 4.3 [0.76, 24.33]
2 studies · 97 participants
Moderate
Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
RR 1.12 [0.4, 2.21]
1 study · 43 participants
Low
Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
RR 1.05 [0.61, 1.83]
2 studies · 97 participants
Moderate